gastroenteritis

PerkinElmer's subsidiary Wallac will now distribute the Amplidiag product line in Israel and in a number of countries in Africa.

Applied Biocode intends to have panel for identifying 18 gastrointestinal pathogens on the clinical market by the end of the year.

The BD Max Enteric Panel is the latest in the BD Max suite of assays that aid in the diagnosis of infectious gastroenteritis.

The impact study included time-motion analysis of all steps for the EBP compared to stool culture.

The firm's approach to panels is more focused than the competition, according to a BD executive.

Xpert Norovirus is a qualitative in vitro diagnostic test for the identification and differentiation of norovirus genogroup I and genogroup II.

The company makes tests with rapid time-to-results intended for high-volume hospital and pathology labs using its proprietary diagnostic technology, 3Base.

NEW YORK (GenomeWeb) – Luminex said after the close of the market on Monday that the US Food and Drug Administration has cleared three additional targets for its xTAG Gastrointestinal Pathogen Panel.

NEW YORK (GenomeWeb) — Finnish molecular diagnostics firm Mobidiag said today that its Amplidiag Bacterial GE assay has received CE IVD marking and is now commercially available in Europe.

NEW YORK (GenomeWeb) – Becton Dickinson today said that the US Food and Drug Administration has cleared for marketing the firm's BD Max Enteric Bacterial Panel for detecting the common causes of bacterial gastroenteritis.

Pages

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.